Dayli Partners logo

Dayli Partners

Asia, Seoul-t'ukpyolsi, South Korea, Seoul

Description

Dayli Partners is an investment firm.

Investor Profile

Dayli Partners has made 6 investments, with 1 in the past 12 months and 0% as lead.

Stage Focus

  • Series C (33%)
  • Series A (33%)
  • Series B (17%)
  • Series Unknown (17%)

Country Focus

  • South Korea (50%)
  • Singapore (17%)
  • Indonesia (17%)
  • United States (17%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Medical Device
  • Internet
  • Wellness
  • 3d Printing
  • Training
  • Genetics
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Dayli Partners frequently co-invest with?

HB Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Hera Capital
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
Muirwoods Ventures
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
SV Investment Partners
North America, Connecticut, United States, Greenwich
Co-Investments: 1
IMM Investment
Asia, Cholla-namdo, South Korea, Kangnam
Co-Investments: 2
QUAD Investment Management
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Golden Gate Ventures
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
Korea Investment Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 2
Heritas Capital
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
KB Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 3

What are some of recent deals done by Dayli Partners?

Aldavar

Daejeon, Taejon-jikhalsi, South Korea

ALDAVER provides incredibly realistic personalized surgical training models using innovative biopolymer materials.

3D PrintingMedicalTraining
Series ADec 7, 2024
Amount Raised: $7,717,944
Y-Biologics

Seoul, Seoul-t'ukpyolsi, South Korea

Y-Biologics is specialized in antibody drug since its inception has focused on research and development

BiotechnologyHealth Care
Series UnknownFeb 24, 2022
Amount Raised: $24,874,487
GenEdit

South San Francisco, California, United States

GenEdit develops next generation therapeutics for genetic diseases through safe and efficient CRISPR/Cas9 delivery.

BiotechnologyGeneticsPharmaceuticalTherapeutics
Series ASep 23, 2021
Amount Raised: $26,000,000
ROKIT Healthcare

Seoul, Seoul-t'ukpyolsi, South Korea

ROKIT Healthcare is a biotechnology company that offers hyper-personalized organ regenerative healthcare solutions.

BiotechnologyHealth CareMedical
Series CJul 9, 2020
Curiox Biosystems

Singapore, Central Region, Singapore

Curiox Biosystems is a bioinstrumentation company spun out of the Agency for Science, Technology, and Research (A*STAR) in Singapore.

BiotechnologyMedical Device
Series BOct 16, 2019
Amount Raised: $15,000,000
Alodokter

Jakarta, Jakarta Raya, Indonesia

Alodokter is a digital health platform that provides an end-to-end digital solution to patients including telemedicine, doctors, and others.

Health CareInternetMedicalWellness
Series COct 15, 2019
Amount Raised: $33,000,000